Oscar Health (NYSE:OSCR) Issues Earnings Results

Oscar Health (NYSE:OSCR) posted its quarterly earnings results on Tuesday. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07), Zacks reports. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Trading Down 3.5 %

NYSE:OSCR traded down $0.55 on Thursday, hitting $15.20. 499,931 shares of the stock were exchanged, compared to its average volume of 3,568,057. The stock has a market capitalization of $3.76 billion, a price-to-earnings ratio of -252.94, a P/E/G ratio of 0.67 and a beta of 1.73. Oscar Health has a 52 week low of $13.05 and a 52 week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company’s 50-day moving average price is $15.18 and its 200 day moving average price is $16.84.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of analyst reports. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $21.56.

Insiders Place Their Bets

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. This represents a 5.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now directly owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. The trade was a 7.36 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Company insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.